ArticlesTop 100 City Destinations Index 2025: Driving Growth and Innovation
ArticlesThe competitive advantage that transforms your business
Articles2026 consumer trends and industry insights [Webinar]
ArticlesRO e-Invoice for individuals – how it works and what are the implications for business partners
ArticlesFrom Search to Searchless Discovery: Competing for Visibility in AI-Led Commerce
InterviewsPUTTING ROMANIAN CORPORATE COMPANIES ON THE INTERNATIONAL BUSINESS SCENE
InterviewsOUR EDGE WILL COME FROM BEING THE MOST DIGITALIZED WHOLESALER IN ROMANIA
InterviewsCOFFEE IS OUR LOVE LANGUAGE
InterviewsBUILDING THE FUTURE OF ENERGY: ENEVO GROUP’S ONE-STOP-SHOP MODEL FOR THE ENERGY TRANSITION
InterviewsROOTED IN ROMANIA, BUILT TO DELIVER TECHNOLOGY FOR THE WORLD - EVANTAGE SOFT MODEL FOR GLOBAL IMPACT
NewsSchneider Electric to become the Official Energy Technology Partner of McLaren Racing
News2026 consumer trends and industry insights
NewsRomania and Italy, the first ones applying handling fee on parcels below 150 euros from outside the EU. Customs duty comes next
NewsVodafone Foundation invests another 1.5 million lei in equipping neonatology units in Romania
NewsRaiffeisen Bank issues a new series of bonds denominated in euros

Horvath: 66% of pharmaceutical and biotech executives anticipate solid profit growth in 2025

Copyright © Horvath Romania - Maria Boldor

Horvath: 66% of pharmaceutical and biotech executives anticipate solid profit growth in 2025

HORVATH ROMANIA

13 May 2025

According to a study conducted by Horvath, 66% of executives in this sector expect profit growth of over 5% in 2025 and 2026

70% of executives believe that artificial intelligence (AI) will significantly transform business models.
60% identify administrative cost reductions as the main driver of profit growth.
Only 14% of companies expect an increase in the number of employees in 2025.

For more information, please see the Romanian version of the article, here.

Authors

foto

HORVATH ROMANIA

See all published materials

Tags : executives , pharmaceutical , biotech , profit , artificial intelligence , AI , business , employees , Life Sciences Executives Flash Report , M&A

© 2026, DoingBusiness.ro

Update cookies preferences